{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:23:08Z","timestamp":1768735388455,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtbi.2024.111767","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:31:39Z","timestamp":1708486299000},"page":"111767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Viral rebound occurrence immediately after drug discontinuation involving neither drug resistance nor latent reservoir"],"prefix":"10.1016","volume":"582","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-3317","authenticated-orcid":false,"given":"Rena","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-6489","authenticated-orcid":false,"given":"Akane","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-1852","authenticated-orcid":false,"given":"Yoh","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtbi.2024.111767_b0005","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0030124","article-title":"Modelling the impact of antiretroviral use in resource-poor settings","volume":"3","author":"Baggaley","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jtbi.2024.111767_b9000","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"New Eng. J. Med."},{"issue":"13","key":"10.1016\/j.jtbi.2024.111767_b0015","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1073\/pnas.94.13.6971","article-title":"Virus dynamics and drug therapy","volume":"94","author":"Bonhoeffer","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.jtbi.2024.111767_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2024.111767_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.801522","article-title":"A detailed overview of immune escape, antibody escape, partial vaccine escape of SARS-CoV-2 and their emerging variants with escape mutations","volume":"13","author":"Chakraborty","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtbi.2024.111767_b0035","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1073\/pnas.1419162112","article-title":"Post-treatment control of HIV infection","volume":"112","author":"Conway","year":"2015","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.jtbi.2024.111767_b0040","doi-asserted-by":"crossref","first-page":"e1007229","DOI":"10.1371\/journal.pcbi.1007229","article-title":"Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers","volume":"15","author":"Conway","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0045","doi-asserted-by":"crossref","first-page":"20201015","DOI":"10.1098\/rsif.2020.1015","article-title":"Unified model of short- and long-term HIV viral rebound for clinical trial planning","volume":"18","author":"Conway","year":"2021","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jtbi.2024.111767_b0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jtbi.2007.03.006","article-title":"Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy","volume":"247","author":"Dahari","year":"2007","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2307\/1938700","article-title":"Elasticity: the relative contribution of demographic parameters to population growth rate","volume":"67","author":"de Kroon","year":"1986","journal-title":"Ecology"},{"issue":"21","key":"10.1016\/j.jtbi.2024.111767_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01028-17","article-title":"Escape of Tick-Borne Flavivirus from 2\u2032- C -Methylated Nucleoside Antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness","volume":"91","author":"Eyer","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2024.111767_b0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jhep.2005.05.037","article-title":"Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation","volume":"43","author":"Fung","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtbi.2024.111767_b0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtbi.2010.08.036","article-title":"Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics","volume":"267","author":"Guedj","year":"2010","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2893.2010.01348.x","article-title":"A perspective on modelling hepatitis C virus infection","volume":"17","author":"Guedj","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jtbi.2024.111767_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2020.110296","article-title":"Autoimmune diseases initiated by a pathogen infection: mathematical modeling","volume":"498","author":"Hara","year":"2020","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1098\/rstb.1997.0002","article-title":"Evolutionary pattern of intra-host pathogen antigen drift: effect of cross-reactivity in immune response","volume":"352","author":"Haraguchi","year":"1997","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111767_b0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.283.2.229","article-title":"Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens","volume":"283","author":"Havlir","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jtbi.2024.111767_b0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11538-023-01184-x","article-title":"Temporal pattern of the emergence of a mutant virus escaping cross-immunity and stochastic extinction within a host","volume":"85","author":"Hayashi","year":"2023","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2022.111029","article-title":"Escaping stochastic extinction of mutant virus: temporal pattern of emergence of drug resistance within a host","volume":"537","author":"Hayashi","year":"2022","journal-title":"J. Theor. Biol."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111767_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12698","article-title":"Insight into treatment of HIV infection from viral dynamics models","volume":"285","author":"Hill","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jtbi.2024.111767_b0110","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"Hurst","year":"2015","journal-title":"Nature Commun."},{"key":"10.1016\/j.jtbi.2024.111767_b0115","first-page":"e1003660","article-title":"Detection of significant antiviral drug effects on COVID019 wit reasonable sample sizes in randomized controlled trials: a modeling study","volume":"18","author":"Iwanami","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0120","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1534\/genetics.105.049791","article-title":"Evolution of resistance in clonal expansion","volume":"172","author":"Iwasa","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.jtbi.2024.111767_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2021.110875","article-title":"Virulence of a virus: how it depends on growth rate, effectors, memory cells, and immune escape","volume":"530","author":"Iwasa","year":"2021","journal-title":"J. Theor. Biol."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111767_b0130","doi-asserted-by":"crossref","first-page":"e3001128","DOI":"10.1371\/journal.pbio.3001128","article-title":"A quantitative model used to compare within-host SARS-CoV- 2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2","volume":"19","author":"Kim","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fviro.2022.933418","article-title":"How to break free: HIV-1 escapes from innovative therapeutic approaches","volume":"2","author":"Magro","year":"2022","journal-title":"Front. Virol."},{"key":"10.1016\/j.jtbi.2024.111767_b0140","doi-asserted-by":"crossref","first-page":"e17956","DOI":"10.1371\/journal.pone.0017956","article-title":"Cumulative viral load and virology: decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recover and AIDS","volume":"6","author":"Marconi","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111767_b0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jtbi.1996.0307","article-title":"Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations","volume":"184","author":"Nowak","year":"1997","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0150","series-title":"Viral Dynamics: Mathematical Principles of Immunology and Virology","first-page":"237","author":"Nowak","year":"2000"},{"key":"10.1016\/j.jtbi.2024.111767_b0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s002390010086","article-title":"Antigen drift of viruses within a host: a finite site model with demographic stochasticity","volume":"51","author":"Sasaki","year":"2000","journal-title":"J. Mol. Evol."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111767_b0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/aje\/kwv303","article-title":"Reevaluating cumulative HIV-1 viral load as a prognostic predictor: predicting opportunistic infection incidence and mortality in a Ugandan cohort","volume":"184","author":"Sempa","year":"2016","journal-title":"Am. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.jtbi.2024.111767_b0165","doi-asserted-by":"crossref","first-page":"e0224723","DOI":"10.1371\/journal.pone.0224723","article-title":"Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models","volume":"14","author":"Sempa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2024.111767_b0170","unstructured":"U.S. Food and Drug Administration, 2023. FDA approves first oral antiviral for treatment of covid-19 in adults. FDA news release (May 25, 2023). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-oral-antiviral-treatment-covid-19-adults."},{"issue":"10","key":"10.1016\/j.jtbi.2024.111767_b0175","doi-asserted-by":"crossref","first-page":"e1008241","DOI":"10.1371\/journal.pcbi.1008241","article-title":"Models of SIV rebound after treatment interruption that involve multiple reactivation events","volume":"16","author":"van Dorp","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jtbi.2024.111767_b0180","doi-asserted-by":"crossref","unstructured":"Wang, L., Berger N.A., Davis, P.B., Kaelber, D.C., Volkow, N.D., Xu, R., 2022. Covid-1 rebound after Paxlovid and Molnupiravar during January-June 2022. medRxiv (preprint) doi: 10.1101\/2022.06.21.22276724.","DOI":"10.1101\/2022.06.21.22276724"},{"key":"10.1016\/j.jtbi.2024.111767_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2020.108438","article-title":"Modeling the viral dynamics of SARS-CoV-2 infection","volume":"328","author":"Wang","year":"2020","journal-title":"Math. Biosci."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111767_b0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B Virus rtA181T\/sW172* mutant has a dominant negative defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jtbi.2024.111767_b0195","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0040177","article-title":"Understanding the slow depletion of memory CD4\u00fe T cells in HIV infection","volume":"4","author":"Yates","year":"2007","journal-title":"PLoS Med."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519324000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519324000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:38:39Z","timestamp":1758386319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519324000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"alternative-id":["S0022519324000481"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2024.111767","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral rebound occurrence immediately after drug discontinuation involving neither drug resistance nor latent reservoir","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2024.111767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111767"}}